Axonics Modulation Technologies Inc. (NASDAQ: AXNX) stock closed at 57.51 per share at the end of the most recent trading day (a -1.81% change compared to the prior day closing price) with a volume of 758.21K shares and market capitalization of 2.67B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 302 people. Axonics Modulation Technologies Inc. CEO is Raymond Wayne Cohen.

The one-year performance of Axonics Modulation Technologies Inc. stock is -11.13%, while year-to-date (YTD) performance is 2.7%. AXNX stock has a five-year performance of %. Its 52-week range is between 38.41 and 79.81, which gives AXNX stock a 52-week price range ratio of 44.03%

Axonics Modulation Technologies Inc. currently has a PE ratio of -32.50, a price-to-book (PB) ratio of 5.95, a price-to-sale (PS) ratio of 13.93, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -16.97%, a ROC of -17.21% and a ROE of -20.70%. The company’s profit margin is -41.32%, its EBITDA margin is -32.30%, and its revenue ttm is $194.34 Million , which makes it $4.13 revenue per share.

Of the last four earnings reports from Axonics Modulation Technologies Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.57 for the next earnings report. Axonics Modulation Technologies Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Axonics Modulation Technologies Inc. is Strong Buy (1.17), with a target price of $70, which is +23.59% compared to the current price. The earnings rating for Axonics Modulation Technologies Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Axonics Modulation Technologies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Axonics Modulation Technologies Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 9.20, ATR14 : 3.65, CCI20 : 104.88, Chaikin Money Flow : 0.07, MACD : 0.73, Money Flow Index : 69.89, ROC : -0.78, RSI : 59.30, STOCH (14,3) : 85.14, STOCH RSI : 0.88, UO : 62.17, Williams %R : -14.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Axonics Modulation Technologies Inc. in the last 12-months were: Alfred J. Ford (Option Excercise at a value of $0), Alfred J. Ford (Sold 9 267 shares of value $447 152 ), Danny L. Dearen (Option Excercise at a value of $986 241), Danny L. Dearen (Sold 88 594 shares of value $4 612 839 ), Jane E. Kiernan (Sold 5 250 shares of value $317 607 ), John Woock (Option Excercise at a value of $79 100), John Woock (Sold 46 251 shares of value $3 027 691 ), Karen Noblett (Option Excercise at a value of $0), Karen Noblett (Sold 20 213 shares of value $1 096 780 ), Raymond Wayne Cohen (Option Excercise at a value of $0), Raymond Wayne Cohen (Sold 185 115 shares of value $11 190 869 ), Rinda Sama (Option Excercise at a value of $0), Rinda Sama (Sold 11 882 shares of value $573 331 )